SPONSORED CONTENT The monkeypox (renamed mpox by the World Health Organization) outbreak took the world by storm in early May […]
SPONSORED CONTENT Increasingly, participants in Accountable Care Organizations (ACOs) are discovering and benefiting from the 340B drug discount program. Unlike […]
SPONSORED CONTENT We are pleased to again bring you Visante’s Top 10 issues in pharmacy for 2023. For 2022, our […]
With increased scrutiny over passing on 340B discounts at the contract pharmacy counter, Hudson Headwaters 340B’s Jim Donnelly explores the […]
Which drugs, therapeutic classes, and medical specialties account for the largest savings realized through referral prescriptions within the contract pharmacy […]
Avita’s CEO Michael Yount and Chief Advocacy Officer Glen Pietrandoni discuss why 340B advocacy is so important and what Avita […]
SPONSORED CONTENT Join Verity Solutions for our next Lunch & Learn webinar session on Thursday, December 15 at 1:30PM ET […]
The article includes sound recommendations for running a high performing 340B program.
Avita is reinforcing its commitment to reducing health inequities by broadening its impact beyond pharmacy services. Learn more here.
Alas, after much deliberation, your covered entity has decided to submit data to 340B ESP. As you embark on this […]